Summary Slide.png (48.11 kB)

Pulmonary Fibrosis Secondary to Oxaliplatin Treatment: From Rarity to Reality: A Case Study & Literature Review

figure

posted on 02.09.2020, 13:30 by Ana C. Moreira, João Portela, Carlos Couto, José Duarte, Natália Martins, Jorge Soares

The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

History

References

https://link.springer.com/article/10.1007/s40487-020-00127-z

Usage metrics

Read the peer-reviewed publication

Pulmonary Fibrosis Secondary to Oxaliplatin Treatment: From Rarity to Reality: A Case Study & Literature Review

Oncology and Therapy

Keywords

Interstitial lung disease Oxaliplatin Respiratory insufficiency Toxicity

Licence

CC BY-NC 4.0

Pulmonary Fibrosis Secondary to Oxaliplatin Treatment: From Rarity to Reality: A Case Study & Literature Review

History

References

Usage metrics

Read the peer-reviewed publication

Categories

Keywords

Licence

Exports